Amy P. Abernethy

Atrium Medical Cente — United States

Medicine · Health Sciences

92h-index35.3kcitations738works16.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Palliative Care and End-of-Life Issues(249), Health Systems, Economic Evaluations, Quality of Life(104), Childhood Cancer Survivors' Quality of Life(100), Cancer survivorship and care(99), Chronic Obstructive Pulmonary Disease (COPD) Research(73)

Publications735 total

Advancing Decentralized and Pragmatic Clinical Trials as a Path Toward Improved Representativeness and Greater Generalizability of Clinical Trial Evidence
Clinical Therapeutics·2025· 2 citedOpen Access
Osseointegration programmatic development: interdisciplinary team with a patient-centered approach
OTA International The Open Access Journal of Orthopaedic Trauma·2025Open Access
Addressing the challenges of integrating digital health technologies to measure patient-centred outcomes in clinical registries
The Lancet Digital Health·2024· 13 citedOpen Access
How AI will transform cancer care
Annals of Oncology·2024· 4 citedOpen Access
Modernizing the Data Infrastructure for Clinical Research to Meet Evolving Demands for Evidence
JAMA·2024· 21 cited
The Integration of Clinical Trials With the Practice of Medicine
JAMA·2024· 57 citedOpen Access
Increasing psychopharmacology clinical trial success rates with digital measures and biomarkers: Future methods
NPP—Digital Psychiatry and Neuroscience·2024· 3 citedOpen Access
Mobilizing data during a crisis: Building rapid evidence pipelines using multi-institutional real world data
Healthcare·2024
Abstract 1311: Planning for health equity in oncology trials: Expectations and feasibility
Cancer Research·2024
https://nam.edu/regenerative-medicine-case-study-for-understanding-and-anticipating-emerging-science-and-technology/
NAM Perspectives·2023· 3 citedOpen Access
Regenerative Medicine: Case Study for Understanding and Anticipating Emerging Science and Technology
NAM Perspectives·2023· 2 cited
Time for real-world health data to become routine
Nature Medicine·2023· 13 cited
Diversity, Equity, and Inclusion in Clinical Research: A Path Toward Precision Health for Everyone
Clinical Pharmacology & Therapeutics·2022· 53 citedOpen Access
ISPE20 Author Index
Pharmacoepidemiology and Drug Safety·2022· 1 citedOpen Access
The Promise of Digital Health: Then, Now, and the Future
NAM Perspectives·2022· 388 citedOpen Access
Digital Health COVID-19 Impact Assessment: Lessons Learned and Compelling Needs
NAM Perspectives·2022· 52 citedOpen Access
Redistribution of Health Care Costs after the Adoption of Positron Emission Tomography among Medicare Beneficiaries with Non–Small-Cell Lung Cancer, 1998–2005
UNC Libraries·2021Open Access
Pretransplantation Assessments and Symptom Profiles: Predicting Transplantation-Related Toxicity and Improving Patient-Centered Outcomes
UNC Libraries·2021Open Access
Summary of Literature on Pediatric Real-world Evidence and Effectiveness
JAMA Pediatrics·2021· 2 citedOpen Access
Stakeholder perspectives on implementing the National Cancer Institute’s patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
UNC Libraries·2020Open Access
page 1 of 37Next →

Frequent Co-authors

David C. Currow(13), Bryce B. Reeve(6), James A. Tulsky(6), Ethan Basch(5), Deborah Schrag(5), S. Yousuf Zafar(5), Janet Bull(4), Arif H. Kamal(4), Jeffrey Peppercorn(3), Lori M. Minasian(3), Tito R. Mendoza(3), Deborah Watkins Bruner(3), Charles S. Cleeland(3), Diane Β. Paul(3), Jeff A. Sloan(3), Tania Shelby‐James(3), James E. Herndon(3), Thomas W. LeBlanc(3), Betty Ferrell(2), Jamie H. Von Roenn(2)